N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine

N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine is a protected L-ornithine derivative bearing an α-amino acid framework with the α-amino group masked as a Boc carbamate and the δ-side-chain amino group protected as an allyloxycarbonyl (Alloc) carbamate. The molecule contains a stereogenic center at the α-carbon consistent with L-ornithine configuration, alongside a pendant (CH2)3 side chain that terminates in a protected primary amine. The Boc and Alloc groups provide orthogonal protection and controlled deprotection behavior, enabling sequential unveiling of the α- and side-chain functionalities for peptide coupling and side-chain derivatization. The carboxylic acid functionality is present as the free acid form (not an ester), supporting standard amino-acid activation chemistry while the protected amines remain non-nucleophilic under coupling conditions.

1. Peptide Synthesis

N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine is used in peptide building workflows where orthogonally protected diamino acid chemistry is required for stepwise chain assembly. The Boc-protected α-amino group supports selective N-terminal coupling, while the Alloc-protected δ-amine can remain masked during early elongation steps and later be revealed for side-chain incorporation. The free carboxylic acid participates in conventional peptide coupling strategies after activation, generating amide bonds without premature side-chain reactivity. Downstream deprotection of the Alloc group enables installation of ornithine-derived motifs, including branched or functionally differentiated peptide segments, making the compound suitable for constructing ornithine-containing peptides and peptidomimetic scaffolds.

2. Side-Chain Functionalization

N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine serves as a controlled platform for ornithine side-chain modification in chemical biology and medicinal chemistry intermediate preparation. The δ-side-chain amine, temporarily protected as an Alloc carbamate, can be selectively unmasked to introduce substituents that probe charge, hydrogen-bonding, or steric effects at the side-chain terminus. The protected amine strategy helps maintain compatibility with conditions used to functionalize the α-amino acid backbone or to assemble protected peptide fragments without uncontrolled cross-reactivity. Resulting derivatives can be carried forward into SAR studies, ligand design, or conjugation-ready ornithine analogs that retain a defined stereochemical relationship to the α-carbon.

3. Protected Amino Acid Chemistry

N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine is applied as an orthogonally protected amino acid intermediate for protected amino acid synthesis and stereochemically defined scaffold construction. The combination of Boc at the α-position and Alloc at the δ-position enables sequential deprotection logic, supporting routes where α- and side-chain amines must be revealed at different stages. The carbamate protections suppress undesired amide formation or side reactions during activation of the carboxylic acid and during coupling to other protected residues. The resulting protected amino acid can be used to prepare ornithine-containing intermediates for peptide coupling chemistry, including C-terminal or internal residue incorporation where side-chain nucleophilicity must be managed.

4. Bioconjugation Chemistry

N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine is suitable for bioconjugation development where an ornithine-derived amine handle is needed for controlled attachment chemistry. The δ-amine can be unmasked from the Alloc group to generate a primary amine suitable for subsequent derivatization into amide-forming linkers, urea/thiourea motifs, or other conjugation-reactive intermediates. The Boc protection helps preserve the α-amino functionality during linker installation, supporting selective functionalization strategies that minimize heterogeneous modification patterns. Downstream conjugation-ready ornithine derivatives can be used to generate labeled peptides, protein modification reagents, or chemical probes that maintain an L-ornithine stereochemical framework.

5. Pharmaceutical Intermediate Preparation

N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine is employed in pharmaceutical intermediate preparation for constructing protected ornithine motifs used in peptide-like active ingredients and peptidomimetic chemotypes. The amino acid backbone and protected amines support manufacturing-relevant synthesis routes that require predictable functional group timing, particularly when coupling ornithine residues into larger protected intermediates. The orthogonal Boc/Alloc protection pattern can be integrated into process chemistry sequences where selective deprotection and subsequent coupling steps are scheduled to avoid protecting-group scrambling. The compound's defined stereochemistry and protected functional groups make it compatible with fine chemical production of ornithine-containing intermediates used for downstream synthesis of complex nitrogen-rich scaffolds.

6. Chemical Manufacturing

N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine is applicable to industrial chemical manufacturing as a chiral, protected amino acid feedstock for nitrogen-functionalized intermediate generation. The stable carbamate protections allow controlled handling during multi-step synthesis, while the free carboxylic acid enables conversion into activated species for amide bond formation in a manufacturing sequence. The orthogonal deprotection design supports stepwise unveiling of the α- and δ-amines, which can be leveraged to produce defined ornithine derivatives for downstream polymer modification, specialty chemical synthesis, or peptide-manufacturing supply chains. The compound thus functions as a chiral intermediate that aligns with amino acid derivatization and protected amino acid synthesis practices used in applied industrial chemistry.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet